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Asthma is a chronic disease characterized by increased airway infl ammation, enhanced mucus production, and constriction of the airways ( 1 ) . The adaptive immune response, in particular Th2 cells, plays a major role in the pathogenesis of airway infl ammation. Th2 cytokines such as IL-4, IL-5, and IL-13 produced by activated CD4 ϩ T cells exacerbate the severity of the disease ( 2 ) . Additionally, an important contribution of B cells in the pathogenesis of asthma is underlined by the central role for IgE in the activation and degranulation of mast cells ( 3 ) .
Allergen-specifi c IgG is also present in the serum of allergic individuals; however, its exact role in asthma and allergy remains controversial ( 4 -8 ) . Allergen hyposensitization therapy involves " tolerizing " atopic individuals by longterm exposure to allergen. The success of this therapy has been correlated to increased serum IgG 4 levels ( 9 ) . Antigen-specifi c IgG has been thought to exert its suppressive eff ects through diff erent pathways that include competing with IgE for allergen epitopes and activation of inhibitory Fc ␥ receptors ( 10 ) . In sharp contrast, a recent study by the Multicentre Allergy Study Group has demonstrated that the presence of antigen-specifi c IgG, in addition to antigenspecifi c IgE, increased the incidence of asthma symptoms in children ( 11 ) . One possible explanation for these contradictory results may be the nature of the IgG isotype produced in each individual, as well as the preferential ligation of certain IgG isotypes to activating versus inhibitory Fc ␥ receptors.
Activating Fc ␥ receptors possess immunoreceptor tyrosine-based activation motifs, whereas inhibitory Fc ␥ receptors possess immunoreceptor tyrosine-based inhibition motifs in their intracellular domain. The activating receptors Fc ␥ RI (CD64) and Fc ␥ RIII (CD16) signal through a common signaling partner FcR ␥ (Fc RI ␥ ), which contains an immunoreceptor tyrosine-based served as the TLR-4 stimulus. Upon Fc receptor ligation, TLR-4 -induced IL-10 production by the bone marrowderived DCs (BMDCs) was signifi cantly up-regulated, whereas IL-12 production was suppressed ( Fig. 1 A ) . The ability of Fc ␥ receptors to modulate BMDC cytokine production was TLR-4 dependent, as OVA-ICs failed to modulate cytokine production from TLR-4 Ϫ / Ϫ DCs. Polymixin B -mediated depletion of LPS from the OVA also abolished the ability of OVA-ICs to infl uence DC cytokine production (unpublished data). Further, Fc ␥ receptor ligation also augmented production of the chemokine monocyte chemoattractant protein (MCP)-1, which has been shown to promote Th2 diff erentiation ( 29 ) .
To physically dissociate the TLR-4 stimulus from Fc ␥ receptor ligation, we sought to cross-link Fc ␥ receptors with an immobilized antibody specifi c for Fc ␥ RIIb/RIII (2.4G2) ( 30, 31 ) . BMDCs were stimulated with 10 ng/ml LPS with varying concentrations of 2.4G2. As found with OVA-IC stimulation, ligation of Fc ␥ receptors on BMDCs with 2.4G2 resulted in a dose-dependent increase in IL-10 and MCP-1 production, and a decrease in IL-12 production ( Fig. 1 B ) . Collectively, these data suggest that Fc ␥ receptor ligation modulates TLR-induced DC functions and augments cytokines known to promote a pro-Th2 milieu. activation motif and is also associated with the high affi nity receptor for IgE. A novel member of the Fc ␥ receptor family, Fc ␥ RIV, has been recently described (12) . Fc ␥ RIV also associates with the FcR ␥ signaling chain, suggesting its role as an activating Fc ␥ receptor ( 12 ) . Fc ␥ RIIb (CD32b) is the sole member of the inhibitory Fc ␥ receptor family in mice and does not associate with FcR ␥ . It has been demonstrated that ligation of the inhibitory Fc ␥ RIIb can suppress Fc receptor signaling and ameliorate airway disease ( 13 ) . Fc ␥ RIIb has also been shown to promote tolerance to inhaled antigens ( 14 ) . Thus, the role of inhibitory Fc ␥ receptors in suppressing Th2-mediated infl ammatory responses is well documented; however, the role of activating Fc ␥ receptors remains unclear.
Activating Fc ␥ receptors have both overlapping and nonredundant roles. Signaling via both Fc ␥ RI and Fc ␥ RIII on macrophages has been demonstrated to enhance phagocytosis of opsonized RBCs and antigen presentation to T cells ( 15, 16 ) . However, evidence of nonredundant roles is provided by studies that demonstrate that both Fc ␥ RI Ϫ / Ϫ and Fc ␥ RIII Ϫ / Ϫ mice exhibit marked defects in their ability to mount Arthus reactions and have reduced susceptibility to passive anaphylaxis ( 16 -18 ) . In addition, the development of proteoglycan-induced arthritis was found to require Fc ␥ RIII but not Fc ␥ RI expression ( 19 ) . The inability of the individual Fc ␥ receptors to compensate for each other may be explained by selective affi nity of each receptor for a subtype of IgG antibodies. Fc ␥ RI binds IgG 2a antibodies with ‫ف‬ 100-fold higher affi nity than Fc ␥ RIII ( 12, 20, 21 ) , and Fc ␥ RI is a high affi nity receptor for monomeric IgG antibodies, whereas Fc ␥ RIII is thought to be a low affi nity receptor that is engaged effi ciently by IgG 1 -immune complexes ( 15, 18 ) .
In this study, we investigated whether activating Fc ␥ receptors regulate Th2-dependent infl ammatory responses. We demonstrate that signaling via Fc ␥ RIII on DCs plays a key role in the development of optimal Th2-dependent airway infl ammation. This augmentation of Th2 immunity by Fc ␥ RIII ligation is distinct from its role in antigen presentation and mediated by IL-10 production by the priming DCs. Our data suggest a novel role for Fc ␥ RIII on DCs in augmenting in vivo Th2 responses and the exacerbation of airway infl ammation.
RESULTS

Ligation of Fc ␥ receptors modulates Toll-like receptor (TLR)-4 -mediated cytokine production from DCs
DCs are thought to play a critical role in the regulation of Th cell diff erentiation ( 22 ) and for the development of airway infl ammation ( 23 -25 ) . As DCs have been shown to express all Fc ␥ receptors ( 12, 26 -28 ) , we investigated the contribution of Fc ␥ receptor ligation in TLR-4 -induced stimulation of DCs. Immune complexes were produced by incubation of OVA with anti-OVA sera (OVA immune complexes [OVAICs]) and used to ligate Fc ␥ receptors. To control for potential nonspecifi c eff ects from the antisera, an aliquot of antisera in which IgG had been depleted was incubated with OVA (OVA-IgG depl ). 22.1 EU/mg endotoxin present in the OVA Fc ␥ RIII as well as the inhibitory receptor Fc ␥ RIIb ( 27 ) . To dissect whether the modulation of DC function was due to activating or inhibitory Fc ␥ receptors, we generated BMDCs from Fc ␥ RIIb − / − and Fc ␥ RIII − / − mice as well as from FcR ␥ − / − mice that lack all activating Fc receptors. Interestingly, modulation of IL-10 and IL-12 production upon 2.4G2 stimulation was dependent on expression of FcR ␥ chain and Fc ␥ RIII, but deletion of Fc ␥ RIIb actually enhanced the changes induced by the activating Fc ␥ receptors ( Fig. 3 A ) . These data suggest that the modulation of cytokine production is dependent on signaling through the activating Fc ␥ receptors and that this signaling can be counteracted by the inhibitory Fc ␥ RIIb.
Ligation of activating Fc ␥ receptors has been shown to activate various signaling pathways including ERK, p38, and phosphatitylinositol-3 kinase (PI3K) ( 33 ) . To ascertain the contribution of these signaling pathways in augmenting IL-10 production from the DCs, we stimulated BMDCs with LPS and 2.4G2 in the presence of selective inhibitors of p38 (SB202190), ERK (U0126), and PI3K (Ly294002) ( Fig. 3 B ) . The PI3K inhibitor blocked 2.4G2-induced IL-10 production in a dose-dependent manner. In contrast, inhibition of ERK and p38 did not result in a signifi cant reduction of IL-10 production. Collectively, these data suggest that signaling via activating Fc ␥ receptors leads to a PI3K-dependent modulation of DC cytokine production.
Ligation of Fc ␥ receptors on the priming DC augments airway infl ammation
To determine if modulation of DC function upon Fc ␥ receptor ligation augments the ability of the DCs to induce Th2-mediated airway infl ammation, we used DCs stimulated with a control rat IgG or 2.4G2 to sensitize naive mice. BMDCs were treated with 2.4G2 or a control antibody in the presence of OVA. After 24 h, the BMDCs were harvested and instilled intratracheally (i.t.) into naive recipients that were subsequently challenged with OVA on days 7, 8, and 9 ( 32 ). The mice were killed 24 h after the last challenge, and the extent of airway infl ammation was assessed by determining the cellular composition in the bronchoalveolar lavage (BAL) fl uid. Mice sensitized with 2.4G2-treated DCs exhibited increased numbers of eosinophils as well as CD4 ϩ T cells compared with mice sensitized with control DCs ( Fig. 2 A ) . Analysis of cytokine production from the CD4 ϩ T cells in the BAL ( Fig. 2 B ) and the lungs ( Fig. 2 C ) BMDCs generated from B6 mice were cultured on a nonspecifi c control rat IgG (open bars) or anti-Fc ␥ RIIb/RIII (2.4G2) (fi lled bars) -coated plates along with OVA. After 24 h, these DCs were harvested and instilled i.t. into naive B6 recipient mice. After sensitization, the recipient mice were challenged with soluble OVA i.t. daily for 3 d starting on day 7, and BAL was performed 24 h after last challenge. (A) Airway infl ammation was assessed by determining the cellular composition of the BAL fl uid (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001). The error bars indicate variation between individual mice. (B) For each group, the BAL cells were pooled and cytokine production of the CD4 ϩ T cells was determined by intracellular staining. (C) Pooled lung cells were restimulated in vitro with OVA for 48 h, and cytokine production was assessed by ELISPOT analysis (**, P Ͻ 0.01; ***, P Ͻ 0.001). The error bars indicate the SEM between replicate stimulations in different wells. The data represented in this fi gure were obtained from three independent experiments, and 9 -10 mice per group were analyzed. IL-5, and IL-13, as well as IL-10 ( Fig. 4 B ) . The amount of IFN-␥ produced by the T cells was relatively low, and no signifi cant changes were observed in IFN-␥ production in any of the experimental groups.
In this experimental system, only the priming DCs had a defect in Fc ␥ RIII expression, whereas the expression of Fc ␥ RIII on all other cells was unaltered. Thus, these data suggest an important role for Fc ␥ RIII signaling on the priming DCs for the stimulatory eff ects of OVA-IC treatment on Th2 responses in vivo. Furthermore, these data suggest a specifi c requirement of Fc ␥ RIII expression on DCs for the augmentation of Th2-mediated airway infl ammation, as other Fc ␥ receptors could not compensate for the defi ciency of Fc ␥ RIII.
Deletion of Fc ␥ RIII on DCs does not diminish their ability to process or present antigens to CD4 ؉ T cells One possible mechanism by which Fc ␥ RIII defi ciency on BMDCs leads to the reduction of Th2 responses could be decreased uptake and processing of immune complexes and diminished antigen presentation to CD4 ϩ T cells. To investigate this possibility, we fi rst analyzed the ability of B6 and Fc ␥ RIII Ϫ / Ϫ BMDCs to internalize and process immunecomplexed antigens. To quantitate the ability of Fc ␥ receptors to enhance uptake and processing of internalized antigens, we used DQ-OVA, a self-quenching conjugate that fl uoresces only upon proteolysis ( 34 ) . Increased fl uorescence in this case would be representative of internalization and processing of antigens, and not just due to increased surface binding of immune-complexed antigens. B6 and Fc ␥ RIII Ϫ / Ϫ DCs were Signaling via Fc ␥ RIII on the priming DCs is required for immune complex -mediated up-regulation of airway infl ammation As Fc ␥ RIII is the sole activating Fc ␥ receptor engaged by 2.4G2, the data from the previous experiments suggested that Fc ␥ RIII signaling could play an important role in the augmentation of Th2-mediated airway infl ammation. To investigate whether Fc ␥ RIII is required for Fc ␥ receptor -mediated augmentation of Th2-dependent airway infl ammation or can be compensated for by other activating Fc ␥ receptors, OVA-ICs were used to ligate Fc ␥ receptors on Fc ␥ RIII Ϫ / Ϫ BMDCs.
BMDCs generated from C57BL/6 (B6) and Fc ␥ RIII Ϫ / Ϫ were cultured with either OVA-IC or control OVA-IgG depl and instilled i.t. to sensitize naive B6 recipients. The recipients were challenged as in Fig. 2 , and the severity of airway infl ammation was determined on day 10. BAL eosinophilia was signifi cantly increased in mice that were sensitized with B6 DCs loaded with OVA-IC as compared with mice sensitized with B6 DCs loaded with OVA-IgG Depl ( Fig. 4 A ) . However, Fc ␥ RIII Ϫ / Ϫ DCs loaded with OVA-IC failed to augment eosinophilia in recipient mice. Similarly, further evaluation of Th2 responses in the LNs revealed an augmentation of IL-4, IL-5, and IL-13 production by T cells from recipients that were sensitized with OVA-IC -loaded B6 DCs. The production of the pleiotropic cytokine IL-10 was also coordinately up-regulated along with the classical Th2 cytokines from T cells stimulated with OVA-IC -loaded B6 DCs. However, OVA-IC -loaded Fc ␥ RIII Ϫ / Ϫ DCs failed to augment production of all bonafi de Th2 cytokines: IL-4, whether Fc ␥ RIII Ϫ / Ϫ DCs had any defect in their ability to prime Th2 diff erentiation. OTII T cells stimulated with B6 DCs loaded with OVA-IC produced augmented levels of Th2 cytokines IL-4, IL-10, and IL-13 as compared with DCs loaded with OVA alone ( Fig. 6 A ) . However, Fc ␥ RIII Ϫ / Ϫ DCs loaded with OVA-IC failed to augment Th2 cytokine production but were able to up-regulate IFN-␥ production from the T cells similar to that induced by B6 DCs loaded with OVA-IC. These data argue that Fc ␥ RIII Ϫ / Ϫ DCs do not have a global impairment in responding to immune complexes but nevertheless fail to augment Th2 cytokine production in these cultures.
Finally, to investigate if the increase in antigen processing was required for augmented Th2 diff erentiation by DCs upon Fc ␥ receptor signaling, we eliminated the need for antigen uptake and processing. Control-or 2.4G2-treated DCs were loaded with the agonist OVA 323 -339 peptide that can directly bind to MHC class II molecules present on the cell surface and hence does not require antigen processing. These DCs were used to stimulate TCR transgenic T cells, and cytokine production from the T cells was assessed. 2.4G2-treated DCs augmented Th2 cytokine production from the T cells as compared with control-treated DCs, even when T cell proliferation induced by these DCs was made independent of antigen uptake and processing ( Fig. 6 B ) . Again, this eff ect was dependent on activating Fc ␥ receptors because 2.4G2 treatment failed to augment the ability of Fc ␥ RIII Ϫ / Ϫ DCs to induce Th2 diff erentiation ( Fig. 6 C ) . Collectively, these data demonstrate that increased antigen presentation by the DCs upon Fc ␥ receptor ligation is not required for the increase in Th2 differentiation and argue for a distinct role for Fc ␥ RIII signaling in regulating DC-directed Th diff erentiation. incubated with DQ-OVA or DQ-OVA-IC for 15 min at 37 ° C to allow for uptake. After extensive washing to remove any un-internalized OVA, the cells were incubated for the indicated times at 37 ° C and amount of processing was quantitated as an increase in FITC fl uorescence. As early as 5 min, both B6 and Fc ␥ RIII Ϫ / Ϫ BMDCs exhibited an enhanced ability to internalize and process DQ-OVA-IC as compared with uncomplexed DQ-OVA ( Fig. 5 A ) . At later time points, similar to B6 DCs, Fc ␥ RIII Ϫ / Ϫ DCs loaded with DQ-OVA-IC exhibited an accelerated rate of processing compared with Fc ␥ RIII Ϫ / Ϫ DCs loaded with uncomplexed DQ-OVA. Thus, neither the ability of the DCs to take up antigen nor the ability of the DCs to augment processing of immune complexes was diminished in the absence of Fc ␥ RIII expression.
To determine whether Fc ␥ RIII Ϫ / Ϫ DCs had an impairment in stimulating T cell proliferation that was distinct from their ability to internalize and process antigens, OVA-pulsed B6 and Fc ␥ RIII Ϫ / Ϫ DCs were used to stimulate proliferation of TCR transgenic T cells from the OVA-specifi c OTII mice. Pulsing DCs with immune complexes dramatically increased proliferation of the responding T cells ( Fig. 5 B ) . However, Fc ␥ RIII Ϫ / Ϫ and B6 DCs were equally effi cient at augmenting T cell proliferation when loaded with OVA-IC. These data demonstrate that Fc ␥ RIII Ϫ / Ϫ DCs exhibit no defect in the ability to internalize, process, or present antigens and can induce expansion of T cells equivalent to that induced by B6 DCs.
Augmentation of Th2 differentiation requires Fc ␥ RIII expression but is independent of increased antigen presentation by the DCs As no appreciable defect was found in the ability of Fc ␥ RIII Ϫ / Ϫ DCs to drive T cell expansion in vitro, we investigated reduced the amount of IL-12 production from IL-10 Ϫ / Ϫ DCs. These data suggest that in addition to the autocrine suppression of IL-12 production induced by IL-10, Fc ␥ receptor ligation leads to distinct signaling events that can suppress IL-12 production in an IL-10 -independent manner. Upon stimulation with OVA-ICs, MCP-1 Ϫ / Ϫ DCs showed augmentation of IL-10 production and a suppression of IL-12 production similar to that induced by OVA-IC -treated B6 DCs (unpublished data).
To determine if production of these cytokines by DCs directly infl uenced Fc ␥ receptor -mediated augmentation of Th2 diff erentiation, we assessed the ability of OVA-ICloaded IL-10 Ϫ / Ϫ or MCP-1 Ϫ / Ϫ DCs to induce Th2 diff erentiation of OTII T cells. Diff erentiation of OTII T cells with IL-10 Ϫ / Ϫ DCs loaded with OVA-IC failed to induce augmented T cell production of IL-4, yet induced increased levels of IFN-␥ ( Fig. 7 B ) . Unexpectedly, OTII T cells stimulated with OVA-IC -loaded MCP-1 Ϫ / Ϫ DCs exhibited no defects in their ability to enhance Th2 diff erentiation ( Fig. 7 C ) . Collectively, our data suggest a central role for IL-10 in augmenting the ability of DCs to direct Th2 diff erentiation upon Fc ␥ receptor ligation, whereas MCP-1 production from the DCs was found to be dispensable.
IL-10 production from the DCs plays a key role in Fc ␥ receptor -mediated augmentation of Th2 differentiation
Although the mechanism by which DCs augment Th2 responses remains controversial, it has been suggested that modulation of DC cytokine production infl uences the diff erentiation status of responding T cells ( 35, 36 ) . Several studies have demonstrated an important role of DC cytokines IL-10 and MCP-1 in the augmentation of Th2 responses ( 29, 37 -39 ) . We demonstrated in Figs. 1 and 3 that ligation of activating Fc ␥ receptors on DCs led to the potent up-regulation of IL-10 and MCP-1. To elucidate the contribution of these cytokines in the modulation of DC function upon Fc ␥ receptor engagement, we stimulated B6, IL-10 Ϫ / Ϫ , and MCP-1 Ϫ / Ϫ BMDCs with control OVA or OVA-IC and analyzed cytokine production from the DCs after 24 h of stimulation.
In agreement with previous reports ( 37, 40 ) , IL-10 Ϫ / Ϫ DCs exhibited increased levels of IL-12 production as compared with B6 DCs when stimulated with OVA ( Fig. 7 A ) . However, ligation of Fc ␥ receptors with OVA-IC signifi cantly Th2 cytokine production was found in CD4 ϩ T cells in the BAL fl uid of mice sensitized with OVA-IC -loaded IL-10 Ϫ / Ϫ as determined by intracellular cytokine analysis ( Fig. 7 E ) . Collectively, these data argue for a central role of DC-derived IL-10 in Fc ␥ receptor -mediated augmentation of Th2 diff erentiation both in vitro and in vivo.
To determine if the failure to augment Th2 diff erentiation upon Fc ␥ receptor ligation of IL-10 Ϫ / Ϫ DCs would result in a corresponding failure to augment airway infl ammation, we assessed the extent of airway infl ammation in the recipient mice described above. Contrary to our expectation, Fc ␥ receptor ligation of IL-10 Ϫ / Ϫ DCs augmented their ability to induce eosinophilia ( Fig. 7 F ) . Furthermore, there was a substantial and signifi cant increase in T cells in the BAL fl uid of mice sensitized with IL-10 − / − DCs whether or not Fc ␥ receptors were ligated. These data suggest that even though Fc ␥ receptor -induced IL-10 contributes to the regulation of We next evaluated if IL-10 production from the priming DCs infl uenced in vivo Fc ␥ receptor -mediated augmentation of Th2 diff erentiation and airway infl ammation. BMDCs generated from B6 or IL-10 Ϫ / Ϫ mice loaded with either OVA-IC or OVA-IgG Depl were used to prime naive B6 recipients as described in Fig. 4 . The recipients were subsequently challenged by i.t. administration of soluble OVA, and the diff erentiation status of T cells in the draining LNs was assessed by determining cytokine production by the cells upon restimulation with antigen. Similar to the results obtained from in vitro experiments, Fc ␥ receptor ligation of IL-10 Ϫ / Ϫ DCs failed to augment production of Th2 cytokines IL-4 and IL-5 from cells in the draining LNs ( Fig. 7 D ) . Priming with IL-10 Ϫ / Ϫ DCs, as compared with priming with B6 DCs, led to an augmentation of IFN-␥ production from draining LNs cells, regardless of whether the DCs were loaded with OVA-IC or OVA-IgG Depl . A similar defect in soma mansoni antigens. This model of sensitization and challenge with S. mansoni antigens is well established and previ ously reported by our lab as well as others ( 41 -44 ) . B6 mice sensitized with S. mansoni eggs and challenged with soluble egg antigen (SEA) develop a robust airway infl ammation consisting of 70 -75% eosinophils, 10 -15% T cells, and 10 -15% macrophages. Furthermore, on the B6 background, this model of sensitization and challenge induces a log increase in airway eosinophilia compared with the OVA model of sensitization and challenge. We have previously established that eosinophilia in our model is totally dependent on both sensitization and challenge ( 42, 44 ) . In the absence of either the sensitization or the challenge, the composition of the small number of BAL cells is predominantly macrophages and CD4 ϩ T cell diff erentiation, IL-10 may not play a role in the augmentation of eosinophilia.
Development of airway infl ammation and airway hyperresponsiveness is impaired in Fc ␥ RIII-defi cient mice
Our data demonstrate that ligation of Fc ␥ receptors on DCs augments their ability to regulate Th2 responses in vitro and in vivo. We thus hypothesized that mice defi cient in activating Fc ␥ receptors would have impaired Th2-dependent infl ammatory responses. To investigate the role of activating Fc ␥ receptors in the development of Th2-mediated airway disease, we assessed the severity of airway infl ammation in FcR ␥ Ϫ / Ϫ , Fc ␥ RI − / − , Fc ␥ RIII Ϫ / Ϫ , and control B6 mice that were sensitized and challenged with noninfectious Schisto- 
, and B6 mice were sensitized with i.p. injection of inactivated S. mansoni eggs on day 0. These mice were challenged with i.t. administration of SEA on day 7. On day 11, the mice were killed and the cellular composition of the BAL fl uid was examined by fl ow cytometry (*, P Ͻ 0.05; **, P Ͻ 0.01). (B) Lung tissues from sensitized and challenged B6 and Fc ␥ RIII Ϫ / Ϫ mice were fi xed in 4% formalin and embedded in paraffi n. The sections were stained with PAS or hematoxylin and eosin as noted. (C) Amount of IgE and SEA-specifi c IgG 1 in the sera of sensitized and challenged mice was estimated by ELISA (**, P Ͻ 0.01; P ϭ 0.0012 obtained by two-way ANOVA analysis). (D) Goblet cell metaplasia, perivascular, and peribronchial infl ammation were scored as described in Materials and methods. Four mice per group were analyzed. (E) Rrs to methacholine was measured at day 4 after challenge (P Ͻ 0.0053 by two-way ANOVA analysis). Data are representative of three independent experiments. production from the lymph node cells of Fc ␥ RI Ϫ / Ϫ mice upon in vitro restimulation (not depicted), demonstrating that there was a specifi c defect in Th2 eff ector functions in Fc ␥ RIII Ϫ / Ϫ mice, but not in Fc ␥ RI Ϫ / Ϫ mice. Thus, in addition indistinguishable from the BAL of mice without sensitization and challenge.
In agreement with our hypothesis, mice lacking all activating Fc ␥ receptors (FcR ␥ Ϫ / Ϫ ) exhibited a decrease in airway infl ammation as represented by the decrease in eosinophils and CD4 ϩ cells in the BAL fl uid as compared with control B6 mice ( Fig. 8 A ) . Deletion of the Fc ␥ RI receptor had no eff ect on the Th2-mediated infl ammatory response; however, there was a signifi cant decrease in the numbers of eosinophils and CD4 ϩ T cells in the BAL fl uid from Fc ␥ RIII Ϫ / Ϫ mice as compared with the control B6 mice. Thus, despite sharing the common FcR ␥ chain, the defect was specifi c to the Fc ␥ RIII receptor.
In addition to increased BAL eosinophilia, goblet cell metaplasia and mucus production are also indicative of the degree of infl ammation. Histological examination of lungs showed that there was a decrease in mucus production as well as in the infl ux of infl ammatory cells in sensitized and challenged Fc ␥ RIII Ϫ / Ϫ mice as compared with sensitized and challenged B6 mice ( Fig. 8, B and D ) . Furthermore, serum IgE levels and antigen-specifi c IgG 1 levels were reduced in Fc ␥ RIII Ϫ / Ϫ mice, suggesting a reduction in the capacity of these mice to mount Th2 responses to S . mansoni antigens ( Fig. 8 C ) . These data support our conclusion that expression of Fc ␥ RIII is required for optimal induction of Th2-mediated airway infl ammation.
Airway hyperresponsiveness is a hallmark of asthma and is often associated with increased airway infl ammation ( 45, 46 ) . To investigate if the reduction in airway infl ammation in Fc ␥ RIII Ϫ / Ϫ mice also leads to a reduction in airway hyperresponsiveness, we measured respiratory system resistance (Rrs) changes in response to methacholine. Sensitized and challenged Fc ␥ RIII Ϫ / Ϫ mice exhibited a reduction in Rrs to graded doses of methacholine as compared with similarly treated B6 mice ( Fig. 8 E ) . Collectively, these data demonstrate that the sensitized and challenged Fc ␥ RIII Ϫ / Ϫ mice develop reduced Th2-dependent infl ammatory responses and show a reduction in many of the major pathological features associated with human asthma.
Fc ␥ RIII ؊ / ؊ mice exhibit reduced in vivo Th2 differentiation and cytokine production To determine if the decrease in airway infl ammation in Fc ␥ RIII Ϫ / Ϫ mice was due to reduction in Th2 diff erentiation, we determined the cytokine production profi le of effector cells in sensitized and challenged mice. Intracellular staining of CD4 ϩ T cells obtained from the lungs of Fc ␥ RIII Ϫ / Ϫ mice demonstrated a defect in the ability to produce the hallmark Th2 cytokines IL-4 and IL-5, but exhibited no defect in IFN-␥ production (representative contour plots are shown in Fig. 9 A, and the mean and SEM of fi ve individual mice per experimental group are shown in Fig. 9 B ) . Similarly, upon in vitro restimulation with antigen, there was a specifi c reduction in IL-4, IL-5, and IL-13 secretion by T cells from the draining lymph nodes, whereas IFN-␥ production was unaff ected ( Fig. 9 C ) . No defect was seen in Th2 cytokine Although our data suggest a role for activating Fc ␥ receptors on DCs in augmenting airway infl ammation, it has been proposed that ligation of Fc ␥ receptors on macrophages limits the severity of airway infl ammation ( 60 ) . Macrophages and DCs play diametrically opposite roles in the regulation of airway infl ammation. Studies have demonstrated a suppressive role for macrophages in airway infl ammation, whereas myeloid DCs are found to be required for the induction and exacerbation of airway infl ammation ( 23, 25, 32, 61 ) . Thus, it is possible that Fc ␥ receptors may have distinct functions in macrophages and DCs. The diff erence in Fc ␥ receptor function on these two cell types is highlighted by the observations that Fc ␥ RI, but not Fc ␥ RIII, has an important role in augmenting IL-10 production from the macrophages ( 62 ) . In contrast to macrophages, our analysis of DCs from individual Fc ␥ receptor -defi cient mice has substantiated a role for Fc ␥ RIII in augmenting LPS-induced IL-10 production independent of any other Fc ␥ receptor.
In our study, we demonstrate a central role of DC-derived IL-10 production in the augmentation of Th2 diff erentiation induced upon Fc ␥ receptor ligation both in vitro and in vivo. Nevertheless, the augmentation of eosinophilia induced by Fc ␥ receptor ligation on the priming DCs was found to be independent of IL-10 production from the DCs. Our data are supported by previous studies that demonstrate that IL-10 Ϫ / Ϫ mice do not have a reduction in eosinophilia associated with mouse models of airway infl ammation, even though IL-5 production is severely attenuated in IL-10 Ϫ / Ϫ mice ( 63, 64 ) . One possible explanation that could account for this disassociation of eosinophilia from Th2 diff erentiation may be that increased expansion of T cells observed in the absence of IL-10 may compensate for the reduction in Th2 cytokine production. Thus, even though IL-5 production was reduced on a per-cell basis ( Fig. 7, D and E) , the increased expansion of T cells observed in the BAL fl uid of mice sensitized with IL-10 Ϫ /Ϫ DCs ( Fig. 7 F ) may result in equivalent levels of IL-5 in the airways and lead to the increase in eosinophilia. A second possible explanation could be that Fc ␥ receptor ligation on DCs may regulate Th2 differentiation and augmentation of eosinophilic infl ammation through distinct mechanisms. In either case, our data establish a clear requirement for Fc ␥ RIII ligation on priming DCs for both the induction of optimal Th2 responses as well as the development of airway infl ammation.
Although our data indicate a clear role for DC-derived IL-10 in the induction of Th2 diff erentiation, other studies have reported that DC-derived IL-10 can induce the development of regulatory T cells that can potently suppress Th2-dependent infl ammatory responses ( 65, 66 ) . One possible explanation for these apparently contradictory roles of IL-10 could be the context in which IL-10 is produced by the DCs. The reports that have suggested a regulatory role for IL-10 characterized the role of DC-derived IL-10 in a model of tolerance induction ( 66 ) . In this system, soluble OVA, in the absence of any TLR stimuli or other adjuvants, was instilled i.t. to induce tolerance. In contrast, all our experimental to the well-established role of IgE -Fc receptor interaction in the exacerbation of allergic hyperresponsiveness, ligation of the activating Fc ␥ RIII receptor can lead to augmented Th2 responses and the pathogenesis of airway disease.
DISCUSSION
This study establishes a role of Fc ␥ RIII in the regulation of DC function that is distinct from its role in augmenting antigen uptake and presentation. We fi nd that signaling through Fc ␥ RIII on BMDCs promotes Th2 diff erentiation and leads to augmented Th2 eff ector responses in vivo. These data extend upon previous fi ndings by now demonstrating a specifi c role of Fc ␥ RIII on DCs for optimal Th2 responses, and by demonstrating that this signal is independent of the role of Fc ␥ RIII in antigen presentation ( 47 ) . Previous studies have suggested that activating Fc ␥ receptors could contribute to the severity of airway infl ammation through the activation of Syk, a downstream kinase by which Fc ␥ receptors are known to augment antigen presentation ( 48 -50 ) . However, we demonstrate that signaling through Fc ␥ RIII augments DCdriven Th2 diff erentiation, even when the DCs are loaded with an agonist peptide, eliminating the need for antigen uptake and processing. Further, we demonstrated that in the absence of Fc ␥ RIII, immune complexes augment antigen presentation and induce augmented T cell proliferation without enhancing Th2 diff erentiation. These data uncouple the role of Fc ␥ RIII in regulating Th2 diff erentiation from its well-accepted role in augmenting antigen uptake and presentation to T cells ( 27, 28, 49, 51 -53 ) , and reveal a novel signaling function of the activating Fc ␥ RIII receptor.
We demonstrate that optimal Th2 responses and airway infl ammation are dependent on Fc ␥ RIII but not Fc ␥ RI expression. Th2-dependent airway infl ammation was induced by immunization with inactivated S. mansoni eggs, which induce potent Th2 immunity accompanied by production of IgG 1 antibodies ( 54 ). This IgG subclass preferentially stimulates Fc ␥ RIII as compared with Fc ␥ RI ( 55 ), and thus antigenspecifi c IgG1 may account for the selective requirement of Fc ␥ RIII in augmenting Th2 responses. Whether Fc ␥ RI signaling has a contributing role in the augmentation of Th2-mediated responses would need to be tested in experimental models where other IgG isotypes predominate.
An alternative and nonmutually exclusive explanation could be that Fc ␥ RI and Fc ␥ RIII have unique cellular expression profi les. In mice, Fc ␥ RIII is expressed on a variety of cell types that have been demonstrated to play a role in allergic disease, including DCs, macrophages, eosinophils ( 56 ) , and mast cells ( 57 ) . In contrast, Fc ␥ RI is primarily expressed on monocytes, macrophages, and DCs ( 58 ) . Signaling via Fc ␥ RIII on mast cells has been demonstrated to induce mast cell degranulation and release of soluble mediators that have a role in the regulation of Th2 diff erentiation ( 59 ) . Although Fc ␥ RI cannot compensate for the requirement of Fc ␥ RIII, a contribution of Fc ␥ RI cannot be ruled out. Thus, multiple mechanisms might contribute to the Th2 defect observed in Fc ␥ RIII Ϫ / Ϫ mice sensitized and challenged with S. mansoni antigens.
We propose that Fc ␥ RIII may play a " co-stimulatory " role and diff erentially modulate TLR-induced DC cytokine production. This co-stimulatory function of Fc ␥ receptors suggests an important link between the innate and adaptive immune responses. Antibody production by B cells could potentially infl uence the activation and function of innate immune cells such as DCs via ligation of Fc ␥ receptors. This idea is further supported by the fi ndings that B cell -defi cient mice produce reduced Th2 responses ( 73, 74 ) . As IgG production occurs relatively late after initial sensitization with antigen, the infl uence of Fc ␥ receptor signaling on DCs during initial priming is less likely. However, Fc ␥ receptor signaling could infl uence the magnitude of ongoing and recall Th2 responses by further augmenting Th2 diff erentiation during secondary responses. Thus, IgG antibodies induced under Th2 conditions may form a feedback loop by ligating Fc ␥ RIII on DCs, thereby enhancing an established infl ammatory Th2 response.
Allergies and asthma are chronic disorders whose severity depends upon continued Th2 responses to the allergen. Our data suggest a central role for activating Fc ␥ receptors in regulating Th2 responses and may provide a molecular basis for the proinfl ammatory role of IgG in diseases such as allergies and asthma. However, depending on its subclass, in addition to activating Fc ␥ receptors allergen-specifi c IgG also has the potential to engage the inhibitory Fc ␥ receptor Fc ␥ RIIb. Interestingly, ligation of the inhibitory receptors has been reported to suppress infl ammatory responses. Zhu et al. (13) have described a chimeric Fel d1 -human Fc ␥ fusion protein that suppresses IgE-mediated mast cell activation by coligation of Fc ␥ RIIb. Further, Fc ␥ RIIb ligation has been shown to augment mucosal tolerance and limit infl ammation to innocuous antigens ( 14 ) . Thus, the relative contributions of diff erent Fc receptor family members in the development and progression of infl ammatory diseases may be exceedingly complex.
Allergen-specifi c IgG may have diff erent functions in distinct infl ammatory processes. This complexity is highlighted by a recent report that suggests that in immediate anaphylactic eff ector responses, which are largely governed by innate cells such as macrophages and mast cells, allergen-specifi c IgG may have a suppressive role ( 75 ) . In contrast, our study addresses the role of allergen-specifi c IgG in the priming of adaptive immune responses that are likely to be of explicit importance in more chronic Th2-mediated diseases.
Additionally, the amount of allergen-specifi c IgG present in the serum of sensitized individuals may also diff erentially infl uence infl ammatory processes. In the same report ( 75 ) , it was demonstrated that the suppressive eff ects of the inhibitory Fc ␥ RIIb were most evident only when the allergen amount was low and the amount of allergen-specifi c IgG was high. It is quite likely that the conditions, in which allergenspecifi c IgG may have an inhibitory role, may not always exist under physiological exposure and response to allergens in a diverse group of individuals. It is in fact tempting to speculate that diff erent genetic predispositions and environmental infl uences may in turn impact on the relative amounts of protocols use the TLR-4 agonist LPS, which is a strong stimulator of proinfl ammatory cytokines and a potent activator of DC functions, in conjunction with Fc ␥ receptor ligation. These DCs are exposed to a " danger " signal and are primed to activate the adaptive immune response. Thus, in the presence of additional proinfl ammatory mediators, IL-10 may serve to modulate the T helper response toward a Th2 bias rather than a tolerogenic response. This hypothesis is also supported by studies that report that ligation of certain proinfl ammatory stimuli, such as the TLR-2 agonist zymosan and Pam-3-Cys, lead to augmented IL-10 production by the DCs, which in turn leads to increased Th2 responses in vitro and in vivo ( 67, 68 ) .
Although our data clearly demonstrate a positive contribution of DC IL-10 production in the augmentation of Th2 diff erentiation upon Fc ␥ RIII engagement, the mechanism by which IL-10 production from the DCs leads to the increased Th2 diff erentiation remains unclear. One mechanism could be that Fc ␥ RIII-mediated increase in DC IL-10 production could directly modulate T cell function. As both T cells and DCs express IL-10 receptors, another likely mechanism could be that IL-10 modulates DC function in an autocrine manner, which in turn aff ects T cell diff erentiation. In fact, suppression of IL-12 production due to the autocrine eff ects of IL-10 has been suggested to play a role in increased Th2 differentiation induced upon treatment of DCs with PGE 2 and steroids ( 69, 70 ) . However, our results with IL-10 Ϫ / Ϫ DCs argue for an alternate role of IL-10 in the augmentation of Th2 diff erentiation induced upon Fc ␥ RIII ligation on DCs. We report that the downmodulation of IL-12 production upon Fc ␥ RIII engagement does not require IL-10 production from the DCs. IL-10 Ϫ / Ϫ DCs potently suppressed IL-12 production upon Fc ␥ receptor engagement ( Fig. 7 A ) . However, IL-10 Ϫ / Ϫ DCs failed to induce Th2 diff erentiation upon Fc ␥ receptor ligation. These data clearly dissociate the ability of Fc ␥ receptors to suppress DC IL-12 production from their ability to promote Th2 diff erentiation and lead us to conclude an alternate and important role of IL-10 production in this process. In support, previous reports have also demonstrated that IL-12 absence or suppression is not suffi cient for the induction of Th2 responses by DCs ( 37 , 71 ) .
The role of IL-10 production from the T cells remains unclear. Our data is in concordance with the model proposed by Umetsu et al. (72) that suggests that Th2 cells and IL-10 -expressing regulatory T cells may have a common precursor and diverge further along their developmental pathway. Whereas Th2 cells express Th2 cytokines such as IL-4, IL-5, and IL-13 in addition to IL-10, regulatory cells either develop to exclusively produce IL-10 or may down modulate the production of the proinfl ammatory Th2 cytokines IL-4, IL-5, and IL-13 while retaining IL-10 production. The cytokine profi le of T cells primed with OVA-IC -loaded DCs exhibits an increase in all of the bonafi de Th2 cytokines in addition to IL-10. Thus, our data support the notion that upon Fc ␥ receptor ligation, DCs bias the generation of Th2 responses and not the generation of regulatory T cells.
Lysate assay (Cambrex). The monoclonal antibody 2.4G2 and the control rat IgG antibody were purifi ed from culture supernatants as described previously ( 77 ) .
Production of BMDCs.
DCs were generated by a technique described by Lutz et al. ( 78 ) . In brief, bone marrow was fl ushed from the femurs of mice, and cells were cultured in bacteriological Petri dishes at 2 ϫ 10 5 cells/ml. The cultures were supplemented with 20 ng/ml GM-CSF (PeproTech) and replenished on days 3 and 6. On day 8, the suspension cells were harvested and found to contain Ͼ85% CD11c ϩ cells.
Stimulation of BMDCs.
For stimulation, 5 ϫ 10 5 BMDCs were cultured in 24-well plates with OVA-IC or OVA-IgG Depl at a fi nal OVA concentration of 100 g/ml. For stimulation with 2.4G2, 24-well plates were coated with 500 l of the indicated concentrations of 2.4G2 or control rat IgG in PBS for 2 h at 37 ° C. BMDCs were transferred to the coated plates and cultured in the presence of 10 ng/ml LPS. Cytokine levels in the supernatant were estimated at 24 h. The level of cytokine produced in DC cultures that were neither stimulated with LPS or OVA-IC is below the level of detection, which is 32 pg/ml for IL-10, 64 pg/ml for IL-12p70, and 80 pg/ml for MCP-1.
Induction and assessment of airway infl ammation. Mice were sensitized and challenged with S . mansoni antigens as described previously ( 41 ) . In brief, mice were immunized i.p. on day 0 with 5,000 inactivated S . mansoni eggs. Mice were challenged on day 7 via i.t. delivery of 5 g SEA and killed 4 d later.
Mice were sensitized to OVA using adoptive transfer of antigen-loaded BMDCs as described previously, with minor modifi cations ( 32 ). 10 6 BMDCs from B6 or Fc ␥ RIII Ϫ / Ϫ mice were loaded with OVA-IgG Depl or OVA-IC (fi nal OVA concentration of 100 g/ml) for 24 h, harvested, and instilled i.t. into naive B6 recipients on day 0. On days 7, 8, and 9, the mice were challenged by i.t. aspiration of 100 g OVA and killed on day 10.
BAL was performed by delivering 0.8 ml cold PBS into the airway via a trachea cannula and gently aspirating the fl uid. The lavage was repeated three times to recover a total volume of 2 -3 ml. The cells were stained with trypan blue to determine viability, and total nucleated cell counts were obtained using a hemocytometer. The percentage of CCR3 ϩ eosinophils, CD4 ϩ T cells, and CD8 ϩ T cells in the BAL was determined using fl ow cytometry.
Histology. Lungs were removed from mice after BAL and fi xed by immersion into 4% formalin. Lobes were sectioned sagitally, embedded in paraffi n, cut into 5-m sections, and stained with hematoxylin and eosin for analysis of cellular infi ltrates or with periodic acid schiff (PAS) for analysis of mucuscontaining cells. The score of peribronchiolar and perivascular infl ammation was determined as described previously ( 44 ) . In brief, for the quantifi cation, the airways were scored on a scale of 0 to 4, with 0 being negative and 1 -4 being positive for PAS-staining bronchi. The extent of mucus production in positive bronchi was scored as follows: 1, 5 -25%; 2, 25 -50%; 3, 50 -75%; and 4, Ͼ75%. Peribronchiolar and perivascular infl ammation was scored as follows: 0, normal; 1, few cells; 2, a ring of infl ammatory cells one -cell layer deep; 3, a ring of infl ammatory cells two-to four-cells deep; and 4, a ring of infl ammatory cells of more than four-cells deep.
Airway responsiveness. Rrs was measured through a computer-controlled small animal ventilator (Flexivent; SCIREQ) as described previously ( 79 ) . Each mouse was challenged with increasing doses of methacholine (0, 10, 20, 40, and 80 g in saline) administered i.v. After each challenge, Rrs was recorded during tidal breathing every 10 s for 2 min. Maximum values of Rrs were taken and expressed in terms of percentage change from baseline after saline aerosol.
Isolation of lung cells. Lungs were disassociated by agitating the tissue for 1 h in 20 ml of digestion buff er (85 U/ml hyaluronidase [Sigma-Aldrich], allergen present in an individual as well as their ability to produce allergen-specifi c IgG antibodies. In any event, these studies are in agreement with our fi ndings that Fc ␥ RIIb can limit Fc ␥ RIII-mediated augmentation of IL-10 production from BMDCs, and together emphasize the importance of selectively targeting diff erent Fc ␥ receptors for treatment of allergic diseases.
Translation of our studies to human DC and Th2 diseases remains to be explored. Interestingly, a report by Banki et al. suggests that, similar to our results, ligation of activating Fc ␥ receptors modulates the function of human DCs ( 76 ) . They demonstrated that cross-linking of CD32a, an activating Fc ␥ receptor, on human DCs induces their functional maturation along with an increase in IL-10 production. Due to diff erences in Fc ␥ receptor expression and function between humans and mice, it is likely that the exact molecular identity of the specifi c Fc ␥ receptor may be diff erent. Nevertheless, it is conceivable that in addition to IgE, allergen-specifi c IgG may also modulate the severity of allergic responses in humans. In light of these reports and our fi ndings, therapeutic strategies such as " allergen hyposensitization " that aim to switch antibody production from IgE to IgG need to take into account the IgG subclasses induced and their relative affi nities for different Fc ␥ receptors. Inadvertent induction of IgG subclasses that activate Fc ␥ RIII may exacerbate rather than ameliorate allergic diseases. Furthermore, therapeutic antibodies clinically used to neutralize proinfl ammatory molecules are largely of the IgG isotypes. Infusion of large doses of these antibodies may lead to the generation of immune complexes, leading to Fc ␥ RIII activation that in turn could bias the CD4 ϩ T cell response toward a Th2 phenotype. Thus, our studies now demonstrate a novel role for Fc ␥ RIII in Th2 diff erentiation that must be considered in the future design of immunotherapies to reduce adverse eff ects on therapeutic effi cacy.
MATERIALS AND METHODS
Mice. Fc ␥ RI Ϫ/Ϫ (18) and Fc ␥ RIII Ϫ/Ϫ (17) mice have been backcrossed 6 and 13 generations, respectively, on the B6 background. Female 8 -12-wkold BALB/c and B6 mice were purchased from The Division of Cancer Treatment at the National Cancer Institute or from Charles River Laboratories. Fc ␥ RIIb Ϫ/Ϫ , FcR␥ Ϫ/Ϫ , and Fc ␥ RIIb Ϫ/Ϫ FcR ␥ Ϫ/Ϫ mice were purchased from Taconic. C.C3-Tlr4 Lps-d mice congenic for the Tlr4 Lps-d interval from C3H/HeJ strain and IL-10 Ϫ/Ϫ mice were purchased from The Jackson Laboratory. MCP-1 Ϫ/Ϫ mice were provided by W.J. Karpus (Northwestern University, Chicago, IL). The OTII TCR (specifi c for OVA 323 -339 peptide) transgenic mice were bred and maintained at the University of Chicago. Animals were housed in a specifi c pathogen-free facility maintained by the University of Chicago Animal Resources Center. The studies detailed herein conform to the principles set forth by the Animal Welfare Act and the National Institutes of Health guidelines for the care and use of animals in biomedical research.
Reagents. Grade V chicken egg OVA and rabbit anti -chicken egg OVA IgG were purchased from Sigma-Aldrich. IgG -OVA-ICs were made by mixing a 4:1 excess of anti-OVA:OVA at 37 ° C for 30 min. To control for nonspecifi c eff ects from the antisera, an aliquot of the sera was passed over a protein G column to deplete all IgG present in the serum. This aliquot was mixed with OVA (OVA-IgG Depl ) and used as the control for OVA-IC. Endotoxin levels present in OVA, OVA-IgG Depl , and OVA-IC were 22.1, 17.8, and 38 EU/mg, respectively, as determined by the Limulus Amebocyte
